All In Biotech

Drug Trial Radar · NCT06135363

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

A Single-center, Open Label Study to Evaluate the Safety,Tolerability and Pharmacokinetics of Multiple Administration of Sufenidone (SC1011) Tablets in Healthy Adult Volunteers

Last checked: Nov 19, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Aug 11, 2022

Primary completion

Jan 14, 2023

Study completion Jan 14, 2023

Sponsor

Lead sponsor
Guangzhou JOYO Pharma Co., LtdIndustry
Sponsor type
Industry
First posted
Nov 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn about the safety, tolerability and pharmacokinetic profiles of SC1011 in healthy conditions. The main questions it aims to answer are: Safety and tolerability profiles in healthy subjects and pharmacokinetic profiles in healthy subjects. Participants will complete the study including screening period, dosing period, and observation period. Investigators will compare the inhibitory activity of SC1011 tablets with pirfenidone capsules against the same biomarkers(e.g. blood TNFα) to see if they are different between the two drugs.

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • SC1011Drug

    SC1011 tablet

  • Placebo tabletDrug

    SC1011-matching placebo tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and severity of adverse events and serious adverse events related drug.Time frame: From baseline to 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Xuhui District Central Hospital

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.